12 de June de 2019

Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:

(i) the cultivation of the cannabis spp. for medical and scientific purposes; and

(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.

For further information, click below to access our full newsletter.

Last related news

4 de September de 2026

On August 27, 2026, the National Council for Advertising Self-Regulation (CONAR) approved, significant updates to the Annex “X” of the Brazilian Advertising … CONAR Tightens Betting Advertising Rules: New Restrictions on Influencers and Stronger Protections for Minors

1 de September de 2026

By means of Ordinance 07/2026, published on September 1, 2026, the BPTO has announced an increase in the monthly limit for fast-track examination … Brazil Increases the Monthly Fast-Track Examination Limit for Telecommunication Patent Applications, Including PPH

Kasznar Leonardos

31 de August de 2026

The Brazilian Data Protection Agency (“ANPD”) has imposed a BRL 153.7 million fine on a tech company, primarily for alleged irregularities in the processing … Brazilian Agency fines tech company BRL 153 Million, raising the bar for digital enforcement